Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for the Treatment or Prevention of Alcoholic Liver Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for the Treatment or Prevention of Alcoholic Liver Disease

Published:2021-11-01 Issue:11 Volume:44 Page:1598-1606
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Koga Takayuki¹,Peters Jeffrey M.²

Affiliation:

1. Laboratory of Hygienic Chemistry, Department of Health Science and Hygiene, Daiichi University of Pharmacy

2. Department of Veterinary and Biomedical Sciences and the Center of Molecular Toxicology and Carcinogenesis, The Pennsylvania State University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/44/11/44_b21-00486/_pdf

Reference143 articles.

1. 1) Sarwar R, Pierce N, Koppe S. Obesity and nonalcoholic fatty liver disease: current perspectives. Diabetes Metab. Syndr. Obes., 11, 533–542 (2018).

2. 2) Gao B, Bataller R. Alcoholic liver disease: Pathogenesis and new therapeutic targets. Gastroenterology, 141, 1572–1585 (2011).

3. 3) Donohue TM Jr. Alcohol-induced steatosis in liver cells. World J. Gastroenterol., 13, 4974–4978 (2007).

4. 4) Zeng T, Zhang C-L, Zhao N, Guan M-J, Xiao M, Yang R, Zhao X-L, Yu L-H, Zhu Z-P, Xie K-Q. Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver. Redox Biol., 14, 295–304 (2018).

5. 5) An L, Wang X, Cederbaum AI. Cytokines in alcoholic liver disease. Arch. Toxicol., 86, 1337–1348 (2012).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation;Frontiers in Cardiovascular Medicine;2024-04-18

2. Elevated levels of alcohol dehydrogenase aggravate ethanol-evoked cardiac remodeling and contractile anomalies through FKBP5-yap-mediated regulation of ferroptosis and ER stress;Life Sciences;2024-04

3. Targeting PPARs for therapy of atherosclerosis: A review;International Journal of Biological Macromolecules;2023-07

4. Novel 1,2,4-oxadiazole compounds as PPAR-α ligand agonists: a new strategy for the design of antitumour compounds;RSC Medicinal Chemistry;2023

5. Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs;Cells;2022-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3